Active-ingredient Dossier
Flucloxacillin Sodium Monohydrate
Active-ingredient Dossier for Flucloxacillin Sodium Monohydrate (beta-lactam antibiotic). Australian brands, products, PBS listings, PBAC outcomes —…
- Brand: FLOPEN VIATRIS
- Brand: FLUCIL
- Brand: STAPHYLEX
- Brand: FLUBICLOX
- Brand: FLUCLOXACILLIN
- Brand: FLUCLOXACILLIN
- Therapeutic area: Infectious Disease
What is
Flucloxacillin Sodium Monohydrate Flucloxacillin Sodium Monohydrate is a beta-lactam antibiotic.
Therapeutic areas
Flucloxacillin Sodium Monohydrate is registered in Infectious Disease, with 13 brands containing this ingredient on the ARTG.
Sponsor landscape
The ingredient is marketed by eight sponsors: Ipca Pharma, Eugia Pharma, Alphapharm, Juno Pharmaceuticals, Aspen Pharmacare, and Baxter Healthcare.
PBS and regulatory activity
Two brands with PBS-listed items contain Flucloxacillin Sodium Monohydrate, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 November 2015, and no AusPARs have been recorded for this ingredient.